Skip to content
Nextera AS logo — Opening a new arena for drug discovery

Nextera AS

Opening a new arena for drug discovery

Founded 2009 Norway Norway 20 employees Seed Biotechnology, Health Care +1

General Information

Company Name Nextera AS
Founded Year 2009
Location Norway Norway
Founders / Decision Makers
Team member Team member
Employees 20
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Nextera AS. To contact Nextera AS, visit nextera.no.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nextera AS compare?

A PDF of Nextera AS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nextera AS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nextera AS

Nextera AS is a biotechnology startup based in Norway founded in 2009. The company's slogan, "Opening a new arena for drug discovery," reflects its mission to revolutionize therapeutic intervention in autoimmunity, chronic inflammatory disorders, and cancer. Nextera's distinctive approach involves modulating diseases at the core of the escalating immune cascade, thus enabling disease-specific treatments without compromising systemic immunity.

The company's strategy focuses on discovering new targets and developing cognate drugs in collaboration with partners to address complex diseases. Nextera's emphasis on patient-centric solutions entails a deep understanding of diseased tissue and underlying immune repertoires, providing the unique capability to decipher clinical material and intervene accordingly.

Nextera received its Seed Round investment on 01 January 2010 from Birk Venture. With a focus on biotechnology, healthcare, and pharmaceuticals, the company aims to make significant contributions in the field of drug and target discovery.

Business keywords: Drug discovery, Therapeutic intervention, Autoimmunity, Chronic inflammatory disorders, Cancer treatment, Target discovery, New targets, Cognate drugs, Complex diseases, Therapies development, Immune system modulation, Clinical material analysis, Diseased tissue focus, Immune cascade, Patient-centered approach

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Birk Venture
01 Jan 2010

Nextera AS Alternatives & Competitors

View All Alternatives
Nextera AS vs

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

Venture round
12 employees
Biotechnology, Health Care
Nextera AS vs
Cullgen Inc.
Cullgen Inc. United States

Powering protein degradation for tomorrow's medicines

Acquired
27 employees
Biotechnology, Pharmaceutical
Nextera AS vs

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

Grant
76 employees
Biotechnology, Medical Devices

FAQ About Nextera AS

Opening a new arena for drug discovery
Nextera AS was founded in 2009.
Nextera AS is headquartered in Norway.
Nextera AS operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Drug discovery, Therapeutic intervention, Autoimmunity and Chronic inflammatory disorders.
Nextera AS has approximately 20 employees.
Nextera AS has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Nextera AS include Tridek-One, Cullgen Inc., OSE Immunotherapeutics, Laminar Pharma, Evommune. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nextera AS and Tridek-One are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nextera AS, https://bouncewatch.com/company/nextera-as, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout